Navigation Links
Bracken to Become Chairman of HCA's Board of Directors Effective Dec. 15
Date:11/2/2009

NASHVILLE, Tenn., Nov. 2 /PRNewswire/ -- HCA has announced that Richard M. Bracken will become chairman of HCA's board of directors, effective December 15, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20050825/CLTH069LOGO )

Bracken will replace Jack O. Bovender, Jr., 64, who will retire from the company, effective that same date. In addition, R. Milton Johnson, HCA's chief financial officer and executive vice president, was elected to the board of directors, also effective December 15, 2009.

"Richard has been an invaluable asset to HCA, and his years in both hospital management and executive leadership with the company provide him with a keen understanding of strategic operations and an appreciation for its culture," said Bovender. "I could not envision a better successor or a more qualified guardian of our company's legacy."

Bracken, 57, has served as president and chief executive officer of HCA since January 1, 2009, and has served as a director of the company since 2002. He was president and chief operating officer from January 2002 to January 2009. A veteran of more than 30 years in the hospital industry, Bracken has been a member of HCA's executive leadership for most of his career, and has held positions at the facility, division, and group levels within the organization.

Johnson, 52, has served 27 years with the company, holding positions as head of HCA's Tax Department and as Controller, before being named CFO and executive vice president in July of 2004.

"Milton is an outstanding addition to our board," said Bracken. "His extensive understanding of the company's financial operations and history of leadership within HCA make him particularly qualified to serve as a director."

HCA and its affiliates operate 163 hospitals and 105 ambulatory surgery centers in 20 states and
'/>"/>

SOURCE HCA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Surgex(TM) Becomes the First and Only BSCG (Banned Substance Control Group) Certified Product Which is Clinically Proven Effective in Sports Recovery and Performance
3. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
4. Family of Three Americans Become Pain Free and Improve Their Quality of Life With Stem Cell Treatment in Mexico
5. Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen-Deprivation Therapy
6. The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
7. Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimers Drug After Flurizans Discontinuation
8. CTMM Becomes One of the Worlds Largest Public-Private Partnerships in Translational Medical Research
9. Fora Care Group Becomes Pioneering Educational Member of the International Society of Vascular Health
10. Baxa Announces IntelliFlowRx(TM) to Become DoseEdge(TM) Dose Management System
11. Sequenom Announces Paul Maier to Become Interim Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 2Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 3Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 4Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 5Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 6Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 7Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 8Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 9Encorium Group Amends LOI with Respect to the Sale of its U S Business 3B 49423 1Encorium Group Amends LOI with Respect to the Sale of its U S Business 3B 49423 2Encorium Group Amends LOI with Respect to the Sale of its U S Business 3B 49423 3Encorium Group Amends LOI with Respect to the Sale of its U S Business 3B 49423 4Weight Watchers Declares Quarterly Dividend 49420 1Weight Watchers Declares Quarterly Dividend 49420 2Misonix Subsidiary Sonora Medical Systems Achieves ISO 17025 Accreditation 49417 1Misonix Subsidiary Sonora Medical Systems Achieves ISO 17025 Accreditation 49417 2Misonix Subsidiary Sonora Medical Systems Achieves ISO 17025 Accreditation 49417 3Misonix Subsidiary Sonora Medical Systems Achieves ISO 17025 Accreditation 49417 4